CellSource (TYO:4880) is executing an absorption-type company split involving its subsidiary, Medibase, and GMO Beauty, according to a Tuesday filing.
The split is planned for May 1, subject to shareholder approval on March 21, with GMO Beauty acquiring the Medibase business and related assets for 300 million yen.
CellSource's shares gained more than 2% recently.
Price (JPY): $835.00, Change: $+21, Percent Change: +2.58%